SlideShare une entreprise Scribd logo
1  sur  26
NARCAN NASAL SPRAY
FOR OPIOID OVERDOSE.
Dien Vu
12/2/2015
1
What was the news?1,2
• FDA approved Narcan nasal spray to treat opioid
overdose on November 18th, 2015.
• The first FDA-approved naloxone that can be
administered as nose spray.
• Fast-track approval and priority review for Narcan
nasal spray.
• Took only 4 months for FDA to approve.
• Adapt Pharma Limited submitted new drug application to
FDA for Narcan nasal spray on July 29th, 2015.
2
Why is Narcan nasal spray approved quickly?1
• Death due to drug overdose is now number 1 cause of
injury death in the U.S.
• Death resulted from respiratory arrest from opioid
overdose.
• Naloxone could reverse opioid overdose and was only
available in injectable forms (syringe and auto-injector.)
• Naloxone nasal spray formulation is much easier to use.
• There has been widely unapproved use of injectable naloxone with
an atomizer that delivers naloxone nasally.
• High risk of contaminated needle stick is eliminated.
3
4
Opioids3,4
• Opioids are painkillers.
• Example: hydrocodone, oxycodone, morphine, codeine,
heroin, hydromorphone, methadone, fentanyl, etc.
• Mechanism:
• Bind to opioid receptors in brains, spinal cords, different
organs, etc.
• Opioid effects on central nervous system:
• Reduce pain.
• Reduce cough reflex.
• Reduce respiration.
• Increase euphoria/mood enhancer.
• Increase sedation.
• Increase nausea/vomiting.
• Increase pupil constriction.
5
Opioid side effects 4,5,6,7
6
Peripheral effects
Opioid dependence vs opioid addiction8
• Central adaptations in brain when opioids are taken chronically.
• Tolerance.
• Dependence.
• Tapering opioid or detoxification cause worsening of pain.
• Powerful driving force for opioid seeker.
• Addiction is the unusual and uncontrollable behaviors of opioid-
seeking to achieve the euphoria effect and satisfy cravings.
• Opioid dosing is extremely important as well as monitoring for
opioid-seeking behaviors.
7
How do you identify drug-seeking patients?9,10
• Recognizing suspicious behaviors:
• Obsessive, pushy, angry, impatient, fabricating a story, etc.
• Doctor shopping/Poly-pharmacies.
• Taking at a higher dose.
• Excessive flattery: “You are the best pharmacist ever!”
• Comes in right before closing.
• Recognizing a fake prescription:
• What to do after identified a fake script?
8
Treatments for opioid dependence11
• Goal: relieve withdrawal symptoms and
psychological craving.
• Treatment options:
• Methadone.
• Buprenorphine.
• Naltrexone.
• Maybe safe to take for even lifetime.
• Do not discontinue without consulting your doctor.
9
Opioids safety12
• If taken as instructed, opioids is safe and effective to
manage pain.
• Abusing opioids can lead to consequences:
• Respiratory depression.
• Deterioration of white matter in brain in heroin users.
• Avoid other substances that further depress the
central nervous system:
• Alcohol.
• Drowsy antihistamines.
• Barbiturates.
• Benzodiazepines.
• Anesthetics.
10
Opioids overdose
reasons13
• Accidentally or purposely takes extra doses.
• Accidentally swallowed by a child or pet.
• Give a prescribed opioid medications to someone else.
• Mixed with other opioids, medications, alcohol, or OTC
medications, etc.
• Illegal opioid overdose (heroin, opium.)
• Recreational use:
• Example: Oxycontin extended releases.
11
Recognizing signs of opioid overdose can help
saving lives.13
• Call 911 immediately if:
• Extremely pale face, clammy to the touch.
• Limp body.
• Purple or blue fingernail or lips.
• Vomiting or making gurgling noise.
• Cant be awakened or unable to speak.
• Slow or stop breathing.
• Slow or stop heart beating.
• Signs and symptoms of opioid toxicity:
• Pin-point pupil.
• Sedation.
• Respiratory depression.
• Low blood pressure and/or low heart rate.
12
Treatments for opioid overdose13,14
• Call 911 if suspecting an overdose.
• Begin CPR rescue if breathing is very weak or
has stopped while waiting for ambulance.
• Treatment: Naloxone.
• Via syringe.
• Via auto-injector.
• Via nasal spray.
13
Benefits of Narcan nasal spray15,16,17
• First line treatment for pre-hospital intervention.
• Lay person use.
• Expend availability and overcome shortage.
• Eliminate risk of contaminated needle stick injury to
healthcare workers.
• People can now use an approved formulation of
nasal spray.
14
Narcan rescue kit18
15
16
How does it apply to pharmacy
practice?1,19,20
• Naloxone is one of the life-saving medications for
medical emergency.
• Save health workers from needle stick injury.
• Easier to use compared to injection formulations.
• Can be used on adults and children.
• Designed for lay person use.
• Controversies:
• Narcan standing order.
• CVS is expanding the sale of Naloxone over-the-counter in
12 more state besides Massachusetts and Rhode Island.
17
Naloxone rescue kits
18
Opioid overdose prevention13
• Always follow instructions.
• Do not take more medications than prescribed.
• Talk to your doctor if the dose is not high enough to
sustain pain.
• Always consult with your doctor or pharmacist.
• Use pill box or pill minder.
• Never mix painkillers with alcohol and other
medications without asking your doctors or
pharmacist.
19
Opioid overdose prevention13
• Store in a high and locked cabinet or drawer.
• Dispose unused medications properly:
• Fentanyl: flush down toilet.
• Grind tablets and mix with coffee grounds or cat litter, seal
and toss in trash.
• Police department drop-off boxes.
• Pharmacy drug-take back program.
20
Abuse-deterrent opioids21,22
• Formulation:
• Physical or chemical barriers.
• Agonist + antagonist combination.
• Aversion.
• Delivery system.
• Prodrug.
• Combination of methods listed above.
• Example:
• Suboxone SL film = agonist + antagonist.
• Exalgo (hydromorphone) = crush and extraction resistant.
• Oxecta (IR oxycodone) = aversion.
• Oxycontin (CR oxycodone) = crush and extraction resistance, aversion.
• Opana ER (oxymorphone) = crush and extraction resistance, aversion.
21
Future directions23
• Monitoring for side-effects.
• Expand prescription drug monitoring programs to multi-
states.
• Tighten up regulations on illegal substances or
prescription drug redistribution among patients.
• Provide interventions right away if patients start to
experience withdrawal symptoms.
• Encourage patients to enroll in rehab programs.
• More patient education.
22
Reference
1. FDA Moves Quickly to Approve Easy-to-use Nasal Spray to Treat Opioid
Overdose. U.S. Food and Drug Administration.
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/UCM47
3505. Last updated 11/19/2015. Accessed 11/27/2015.
2. Narcan Approval History. http://www.drugs.com/history/narcan.html.
Accessed 11/27/2015.
3. What Are Opioids? National Institute on Drug Abuse.
http://www.drugabuse.gov/publications/research-reports/prescription-
drugs/opioids/what-are-opioids. Accessed on 11/27/2015.
4. Al-Hasani, R, Bruchas MR. Molecular Mechanisms of Opioid Receptor-
Dependent Signaling and Behavior. Anesthesiology. 2011 Dec; 115(6):
1363-1381.
5. DiPiro, JT, Talbert RL, Yee, GC, et al. Opioid. In: Pharmacotherapy: A
Pathaophysiology Approach. 9e. United States: McGraw-Hill Education;
2014.
6. Swegle JM, Logemann C. Management of Common Opioid-Induced
Adverse Effects. Am Fam Physician. 2006 Oct 15;74(8):1347-1354.
7. Rahman A, Choudhary MI. Frontiers in CNS Drug Discovery. Bentham
Science Publishers, Jan 1,2010.
8. Ballantyne JC, Sullivan MD, Kolodny A. Opioid Dependence vs Addiction.
Arch Intern Med. 2012; 172(17):1342-1343
23
Reference
9. Pretorius RW, Zurick GM. A Systematic Approach to Identifying Drug-Seeking Patients. Fam
Pract Manag. 2008 Apr; 15(4):A3-A5.
10. Spera B. How to Spot and Handle Fake Rxs. http://drugtopics.modernmedicine.com/drug-
topics/news/clinical/community-pharmacy/how-spot-and-handle-fake-rxs?page=full. Last
updated 8/6/2007. Accessed 11/27/2015.
11. Medication and Counseling Treatment. Substance Abuse and Mental Health Service
Administration. http://www.samhsa.gov/medication-assisted-
treatment/treatment#medications-used-in-mat. Last updated 9/28/2015. Accessed
11/27/2015.
12. CNS depressants. National Institute on Drug Abuse.
http://www.drugabuse.gov/publications/research-reports/prescription-drugs/cns-depressants.
Last updated 11/2014. Accessed 11/27/2015.
13. Opioid Overdose. Substance Abuse and Mental Health Service Administration.
http://www.samhsa.gov/medication-assisted-treatment/treatment/opioid-overdose. Last
updated 9/25/2015. Accessed 11/25/2015.
14. Federal Guidelines for Opioid Treatment Programs. Substance Abuse and Mental Health
Service Administration. http://store.samhsa.gov/shin/content//PEP15-
FEDGUIDEOTP/PEP15-FEDGUIDEOTP.pdf. Last updated 3/2015. Accessed 11/27/2015.
15. Furlano, E. Naloxone’s Basic Benefit. http://www.emsworld.com/article/11625142/naloxone-
use-by-emts. EMSWorld. Last updated 10/15/2014. Accessed 11/27/2015.
16. Nasal Spray Naloxone One Step Closer to Public Availability, National Institue on Drug
Abuse. https://www.drugabuse.gov/news-events/news-releases/2015/06/nasal-spray-
naloxone-one-step-closer-to-public-availability. Last updated 6/12/2015. Accessed
24
Reference
17. Kim D, Irwin KS, Khoshnood K. Expanded Access to Naloxone: Options for Critical
Response to The Epidemic of Opioid Overdose Mortality. AM J Public Health. 2009
March;99(3): 402-407.
18. Overdose Prevention and Survival. The Drug Overdose Prevention and Education
Project. http://harmreduction.org/wp-content/uploads/2012/02/dope-brochure-sept-
2010.pdf. Accessed 11/27/2015.
19. CVS to Sell Over-the-counter Narcan in 12 New States. http://www.ems1.com/ems-
news/9948048-CVS-to-sell-over-the-counter-Narcan-in-12-new-states/ Last updated
9/30/2015. Accessed 11/27/2015.
20. CVS Set to Expand Drug Reversing Effect of Heroin Overdoses.
http://www.nbcnews.com/nightly-news/video/cvs-set-to-expand-drug-reversing-effect-
of-heroin-overdoses-533323331609. Last updated 9/27/2015. Accessed 11/27/2015.
21. Abuse-Deterrent Opioids – Evaluation and Labeling- Draft. U.S. Food and Drug
Administration.
http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm
334807.htm. Accessed 11/27/2015.
22. Opioids with Abuse Deterrent Properties. http://www.empr.com/clinical-charts/opioids-
with-abuse-deterrent-properties/article/333126/. Last updated 2/7/2014. Accessed
11/27/2015.
23. Opioid Overdose ToolKit. Substance Abuse and Mental Health Service Administration.
https://store.samhsa.gov/shin/content/SMA13-4742/Overdose_Toolkit_2014_Jan.pdf.
25
Question?
• Thank you!
26

Contenu connexe

Tendances

Tendances (20)

Organophosphorus poisioning.pptx
Organophosphorus poisioning.pptxOrganophosphorus poisioning.pptx
Organophosphorus poisioning.pptx
 
Phenytoin
PhenytoinPhenytoin
Phenytoin
 
Organophosphate poisoning and its management
Organophosphate poisoning and its managementOrganophosphate poisoning and its management
Organophosphate poisoning and its management
 
HYPOGLYCEMIC AGENTS.pptx
HYPOGLYCEMIC AGENTS.pptxHYPOGLYCEMIC AGENTS.pptx
HYPOGLYCEMIC AGENTS.pptx
 
Drugs for leprosy
Drugs for leprosyDrugs for leprosy
Drugs for leprosy
 
Topirol (Topiramate Tablets)
Topirol (Topiramate Tablets)Topirol (Topiramate Tablets)
Topirol (Topiramate Tablets)
 
5.2 drugs used on bronchial asthma
5.2 drugs used on bronchial asthma5.2 drugs used on bronchial asthma
5.2 drugs used on bronchial asthma
 
Deflazacort
DeflazacortDeflazacort
Deflazacort
 
Drug utilization evaluation(DUE) & Drug utilization review)
Drug utilization evaluation(DUE) & Drug utilization review)Drug utilization evaluation(DUE) & Drug utilization review)
Drug utilization evaluation(DUE) & Drug utilization review)
 
Tuberculosis pharmacotherapy
Tuberculosis pharmacotherapyTuberculosis pharmacotherapy
Tuberculosis pharmacotherapy
 
PHARMA- DRUGS FOR RESPIRATORY DISORDERS
PHARMA- DRUGS FOR RESPIRATORY DISORDERSPHARMA- DRUGS FOR RESPIRATORY DISORDERS
PHARMA- DRUGS FOR RESPIRATORY DISORDERS
 
Tobacco poisoning
Tobacco poisoningTobacco poisoning
Tobacco poisoning
 
Peptic ulcer disease pharmacotherapy
Peptic ulcer disease pharmacotherapyPeptic ulcer disease pharmacotherapy
Peptic ulcer disease pharmacotherapy
 
Drugs used to treat peptic ulcer disease
Drugs used to treat peptic ulcer diseaseDrugs used to treat peptic ulcer disease
Drugs used to treat peptic ulcer disease
 
Pharmacology Review Chapter 29-38
Pharmacology Review Chapter 29-38Pharmacology Review Chapter 29-38
Pharmacology Review Chapter 29-38
 
Inhaler medication devices and patient counselling.
Inhaler medication devices and patient counselling.Inhaler medication devices and patient counselling.
Inhaler medication devices and patient counselling.
 
Dexamethasone
Dexamethasone Dexamethasone
Dexamethasone
 
Anti Tuberculosis
Anti TuberculosisAnti Tuberculosis
Anti Tuberculosis
 
Gout And Antigout Drugs
Gout  And Antigout DrugsGout  And Antigout Drugs
Gout And Antigout Drugs
 
Cobix (Celecoxib Capsules)
Cobix (Celecoxib Capsules)Cobix (Celecoxib Capsules)
Cobix (Celecoxib Capsules)
 

En vedette

Naloxone admin
Naloxone adminNaloxone admin
Naloxone admin
timmct
 
Naloxone (prenoxad) presentation (not official)
Naloxone (prenoxad) presentation (not official)Naloxone (prenoxad) presentation (not official)
Naloxone (prenoxad) presentation (not official)
Kevin Jaffray
 
Hot Button Narcan - Draper
Hot Button Narcan - DraperHot Button Narcan - Draper
Hot Button Narcan - Draper
Ed Draper
 
Naloxone presentation for Idaho Board of Pharmacy 2
Naloxone presentation for Idaho Board of Pharmacy 2Naloxone presentation for Idaho Board of Pharmacy 2
Naloxone presentation for Idaho Board of Pharmacy 2
Robert Cole
 
Duo Dote Logo Style Gd
Duo Dote Logo  Style GdDuo Dote Logo  Style Gd
Duo Dote Logo Style Gd
tkeane082876
 

En vedette (20)

REVIVE! Opioid Overdose and Naloxone Education
REVIVE! Opioid Overdose and Naloxone Education REVIVE! Opioid Overdose and Naloxone Education
REVIVE! Opioid Overdose and Naloxone Education
 
Naloxone – saving lives
Naloxone – saving livesNaloxone – saving lives
Naloxone – saving lives
 
Naloxone
NaloxoneNaloxone
Naloxone
 
Teaching narcan injection
Teaching narcan injectionTeaching narcan injection
Teaching narcan injection
 
Naloxone admin
Naloxone adminNaloxone admin
Naloxone admin
 
Tics
TicsTics
Tics
 
Naloxone (prenoxad) presentation (not official)
Naloxone (prenoxad) presentation (not official)Naloxone (prenoxad) presentation (not official)
Naloxone (prenoxad) presentation (not official)
 
Hot Button Narcan - Draper
Hot Button Narcan - DraperHot Button Narcan - Draper
Hot Button Narcan - Draper
 
Naloxone presentation for Idaho Board of Pharmacy 2
Naloxone presentation for Idaho Board of Pharmacy 2Naloxone presentation for Idaho Board of Pharmacy 2
Naloxone presentation for Idaho Board of Pharmacy 2
 
Naloxone Training Presentation
Naloxone Training Presentation Naloxone Training Presentation
Naloxone Training Presentation
 
EMS Provider Quick Reference Guide
EMS Provider Quick Reference GuideEMS Provider Quick Reference Guide
EMS Provider Quick Reference Guide
 
Ems world expo naloxone 11112014.handout
Ems world expo naloxone 11112014.handoutEms world expo naloxone 11112014.handout
Ems world expo naloxone 11112014.handout
 
1st responder nasal naloxone
1st responder nasal naloxone1st responder nasal naloxone
1st responder nasal naloxone
 
2/12/2015 - Project Lazarus
2/12/2015 - Project Lazarus2/12/2015 - Project Lazarus
2/12/2015 - Project Lazarus
 
Duo Dote Logo Style Gd
Duo Dote Logo  Style GdDuo Dote Logo  Style Gd
Duo Dote Logo Style Gd
 
dr. Ike - update on opioid pharmacology
dr. Ike - update on opioid pharmacologydr. Ike - update on opioid pharmacology
dr. Ike - update on opioid pharmacology
 
Ct ems naloxone_bls_training_27may2014 PPT
Ct ems naloxone_bls_training_27may2014 PPTCt ems naloxone_bls_training_27may2014 PPT
Ct ems naloxone_bls_training_27may2014 PPT
 
Rx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_groupRx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_group
 
Cost Effectiveness Analysis
Cost Effectiveness AnalysisCost Effectiveness Analysis
Cost Effectiveness Analysis
 
Opioid analgesic
Opioid analgesicOpioid analgesic
Opioid analgesic
 

Similaire à Narcan nasal spray FINAL

Ct ems naloxone_bls_training_27may2014 (2)
Ct ems naloxone_bls_training_27may2014 (2)Ct ems naloxone_bls_training_27may2014 (2)
Ct ems naloxone_bls_training_27may2014 (2)
dinterlandi
 
Pocket guide-medication-assisted-treatment-for-opioid-disorder
Pocket guide-medication-assisted-treatment-for-opioid-disorderPocket guide-medication-assisted-treatment-for-opioid-disorder
Pocket guide-medication-assisted-treatment-for-opioid-disorder
Mike Wilhelm
 
OEND pharmacist slides - updated 9.3.2016-2
OEND pharmacist slides - updated 9.3.2016-2OEND pharmacist slides - updated 9.3.2016-2
OEND pharmacist slides - updated 9.3.2016-2
Rafael Otero De Santiago
 

Similaire à Narcan nasal spray FINAL (20)

Opioid Addiction Signs, Side effects, and Treatments
Opioid Addiction Signs, Side effects, and TreatmentsOpioid Addiction Signs, Side effects, and Treatments
Opioid Addiction Signs, Side effects, and Treatments
 
Psychopharmacology
PsychopharmacologyPsychopharmacology
Psychopharmacology
 
Getting the low down on prescription opioids: Learn how to notice the signs a...
Getting the low down on prescription opioids: Learn how to notice the signs a...Getting the low down on prescription opioids: Learn how to notice the signs a...
Getting the low down on prescription opioids: Learn how to notice the signs a...
 
Preventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB Policy
Preventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB PolicyPreventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB Policy
Preventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB Policy
 
Ct ems naloxone_bls_training_27may2014 (2)
Ct ems naloxone_bls_training_27may2014 (2)Ct ems naloxone_bls_training_27may2014 (2)
Ct ems naloxone_bls_training_27may2014 (2)
 
Buprenorphine And Naloxone Sublingual Film For Opioid Recovery
Buprenorphine And Naloxone Sublingual Film For Opioid RecoveryBuprenorphine And Naloxone Sublingual Film For Opioid Recovery
Buprenorphine And Naloxone Sublingual Film For Opioid Recovery
 
Alex Evans Intro to Pharmacy
Alex Evans Intro to PharmacyAlex Evans Intro to Pharmacy
Alex Evans Intro to Pharmacy
 
Pocket guide-medication-assisted-treatment-for-opioid-disorder
Pocket guide-medication-assisted-treatment-for-opioid-disorderPocket guide-medication-assisted-treatment-for-opioid-disorder
Pocket guide-medication-assisted-treatment-for-opioid-disorder
 
Pharm Understanding Your Medications
Pharm Understanding Your MedicationsPharm Understanding Your Medications
Pharm Understanding Your Medications
 
PSYCHOPHARMACOLOGY
PSYCHOPHARMACOLOGYPSYCHOPHARMACOLOGY
PSYCHOPHARMACOLOGY
 
Module C week 4
Module C week 4 Module C week 4
Module C week 4
 
Naloxone pilot intranasal_admin_presentation
Naloxone pilot intranasal_admin_presentationNaloxone pilot intranasal_admin_presentation
Naloxone pilot intranasal_admin_presentation
 
A Guide to Opioids
A Guide to OpioidsA Guide to Opioids
A Guide to Opioids
 
Overdose awareness and harm reduction
Overdose awareness and harm reductionOverdose awareness and harm reduction
Overdose awareness and harm reduction
 
Tackling the Opioid Problem - Analgesic Prescribing in the Emergency Department
Tackling the Opioid Problem - Analgesic Prescribing in the Emergency DepartmentTackling the Opioid Problem - Analgesic Prescribing in the Emergency Department
Tackling the Opioid Problem - Analgesic Prescribing in the Emergency Department
 
OEND pharmacist slides - updated 9.3.2016-2
OEND pharmacist slides - updated 9.3.2016-2OEND pharmacist slides - updated 9.3.2016-2
OEND pharmacist slides - updated 9.3.2016-2
 
Prescription opioids and the opiate epidemic
Prescription opioids and the opiate epidemicPrescription opioids and the opiate epidemic
Prescription opioids and the opiate epidemic
 
OpioidUse
OpioidUseOpioidUse
OpioidUse
 
Opioid Use
Opioid Use Opioid Use
Opioid Use
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 

Plus de Dien Vu

Compounding 2 - Allergy skin test
Compounding 2 - Allergy skin testCompounding 2 - Allergy skin test
Compounding 2 - Allergy skin test
Dien Vu
 
OTITIS MEDIA
OTITIS MEDIAOTITIS MEDIA
OTITIS MEDIA
Dien Vu
 
HPV update in pharmacy
HPV update in pharmacyHPV update in pharmacy
HPV update in pharmacy
Dien Vu
 
AuviQ presentation
AuviQ presentationAuviQ presentation
AuviQ presentation
Dien Vu
 
Osteoporosis flyer FINAL
Osteoporosis flyer FINALOsteoporosis flyer FINAL
Osteoporosis flyer FINAL
Dien Vu
 
Asthma flyer
Asthma flyerAsthma flyer
Asthma flyer
Dien Vu
 
Diabetes flyer
Diabetes flyerDiabetes flyer
Diabetes flyer
Dien Vu
 
Board of Pharmacy Updates
Board of Pharmacy UpdatesBoard of Pharmacy Updates
Board of Pharmacy Updates
Dien Vu
 
Herbal and OTC poster
Herbal and OTC posterHerbal and OTC poster
Herbal and OTC poster
Dien Vu
 
Medication Safety Presentation
Medication Safety PresentationMedication Safety Presentation
Medication Safety Presentation
Dien Vu
 

Plus de Dien Vu (13)

PE
PEPE
PE
 
C.Diff
C.DiffC.Diff
C.Diff
 
Compounding 2 - Allergy skin test
Compounding 2 - Allergy skin testCompounding 2 - Allergy skin test
Compounding 2 - Allergy skin test
 
OTITIS MEDIA
OTITIS MEDIAOTITIS MEDIA
OTITIS MEDIA
 
Ozone
OzoneOzone
Ozone
 
HPV update in pharmacy
HPV update in pharmacyHPV update in pharmacy
HPV update in pharmacy
 
AuviQ presentation
AuviQ presentationAuviQ presentation
AuviQ presentation
 
Osteoporosis flyer FINAL
Osteoporosis flyer FINALOsteoporosis flyer FINAL
Osteoporosis flyer FINAL
 
Asthma flyer
Asthma flyerAsthma flyer
Asthma flyer
 
Diabetes flyer
Diabetes flyerDiabetes flyer
Diabetes flyer
 
Board of Pharmacy Updates
Board of Pharmacy UpdatesBoard of Pharmacy Updates
Board of Pharmacy Updates
 
Herbal and OTC poster
Herbal and OTC posterHerbal and OTC poster
Herbal and OTC poster
 
Medication Safety Presentation
Medication Safety PresentationMedication Safety Presentation
Medication Safety Presentation
 

Narcan nasal spray FINAL

  • 1. NARCAN NASAL SPRAY FOR OPIOID OVERDOSE. Dien Vu 12/2/2015 1
  • 2. What was the news?1,2 • FDA approved Narcan nasal spray to treat opioid overdose on November 18th, 2015. • The first FDA-approved naloxone that can be administered as nose spray. • Fast-track approval and priority review for Narcan nasal spray. • Took only 4 months for FDA to approve. • Adapt Pharma Limited submitted new drug application to FDA for Narcan nasal spray on July 29th, 2015. 2
  • 3. Why is Narcan nasal spray approved quickly?1 • Death due to drug overdose is now number 1 cause of injury death in the U.S. • Death resulted from respiratory arrest from opioid overdose. • Naloxone could reverse opioid overdose and was only available in injectable forms (syringe and auto-injector.) • Naloxone nasal spray formulation is much easier to use. • There has been widely unapproved use of injectable naloxone with an atomizer that delivers naloxone nasally. • High risk of contaminated needle stick is eliminated. 3
  • 4. 4
  • 5. Opioids3,4 • Opioids are painkillers. • Example: hydrocodone, oxycodone, morphine, codeine, heroin, hydromorphone, methadone, fentanyl, etc. • Mechanism: • Bind to opioid receptors in brains, spinal cords, different organs, etc. • Opioid effects on central nervous system: • Reduce pain. • Reduce cough reflex. • Reduce respiration. • Increase euphoria/mood enhancer. • Increase sedation. • Increase nausea/vomiting. • Increase pupil constriction. 5
  • 6. Opioid side effects 4,5,6,7 6 Peripheral effects
  • 7. Opioid dependence vs opioid addiction8 • Central adaptations in brain when opioids are taken chronically. • Tolerance. • Dependence. • Tapering opioid or detoxification cause worsening of pain. • Powerful driving force for opioid seeker. • Addiction is the unusual and uncontrollable behaviors of opioid- seeking to achieve the euphoria effect and satisfy cravings. • Opioid dosing is extremely important as well as monitoring for opioid-seeking behaviors. 7
  • 8. How do you identify drug-seeking patients?9,10 • Recognizing suspicious behaviors: • Obsessive, pushy, angry, impatient, fabricating a story, etc. • Doctor shopping/Poly-pharmacies. • Taking at a higher dose. • Excessive flattery: “You are the best pharmacist ever!” • Comes in right before closing. • Recognizing a fake prescription: • What to do after identified a fake script? 8
  • 9. Treatments for opioid dependence11 • Goal: relieve withdrawal symptoms and psychological craving. • Treatment options: • Methadone. • Buprenorphine. • Naltrexone. • Maybe safe to take for even lifetime. • Do not discontinue without consulting your doctor. 9
  • 10. Opioids safety12 • If taken as instructed, opioids is safe and effective to manage pain. • Abusing opioids can lead to consequences: • Respiratory depression. • Deterioration of white matter in brain in heroin users. • Avoid other substances that further depress the central nervous system: • Alcohol. • Drowsy antihistamines. • Barbiturates. • Benzodiazepines. • Anesthetics. 10
  • 11. Opioids overdose reasons13 • Accidentally or purposely takes extra doses. • Accidentally swallowed by a child or pet. • Give a prescribed opioid medications to someone else. • Mixed with other opioids, medications, alcohol, or OTC medications, etc. • Illegal opioid overdose (heroin, opium.) • Recreational use: • Example: Oxycontin extended releases. 11
  • 12. Recognizing signs of opioid overdose can help saving lives.13 • Call 911 immediately if: • Extremely pale face, clammy to the touch. • Limp body. • Purple or blue fingernail or lips. • Vomiting or making gurgling noise. • Cant be awakened or unable to speak. • Slow or stop breathing. • Slow or stop heart beating. • Signs and symptoms of opioid toxicity: • Pin-point pupil. • Sedation. • Respiratory depression. • Low blood pressure and/or low heart rate. 12
  • 13. Treatments for opioid overdose13,14 • Call 911 if suspecting an overdose. • Begin CPR rescue if breathing is very weak or has stopped while waiting for ambulance. • Treatment: Naloxone. • Via syringe. • Via auto-injector. • Via nasal spray. 13
  • 14. Benefits of Narcan nasal spray15,16,17 • First line treatment for pre-hospital intervention. • Lay person use. • Expend availability and overcome shortage. • Eliminate risk of contaminated needle stick injury to healthcare workers. • People can now use an approved formulation of nasal spray. 14
  • 16. 16
  • 17. How does it apply to pharmacy practice?1,19,20 • Naloxone is one of the life-saving medications for medical emergency. • Save health workers from needle stick injury. • Easier to use compared to injection formulations. • Can be used on adults and children. • Designed for lay person use. • Controversies: • Narcan standing order. • CVS is expanding the sale of Naloxone over-the-counter in 12 more state besides Massachusetts and Rhode Island. 17
  • 19. Opioid overdose prevention13 • Always follow instructions. • Do not take more medications than prescribed. • Talk to your doctor if the dose is not high enough to sustain pain. • Always consult with your doctor or pharmacist. • Use pill box or pill minder. • Never mix painkillers with alcohol and other medications without asking your doctors or pharmacist. 19
  • 20. Opioid overdose prevention13 • Store in a high and locked cabinet or drawer. • Dispose unused medications properly: • Fentanyl: flush down toilet. • Grind tablets and mix with coffee grounds or cat litter, seal and toss in trash. • Police department drop-off boxes. • Pharmacy drug-take back program. 20
  • 21. Abuse-deterrent opioids21,22 • Formulation: • Physical or chemical barriers. • Agonist + antagonist combination. • Aversion. • Delivery system. • Prodrug. • Combination of methods listed above. • Example: • Suboxone SL film = agonist + antagonist. • Exalgo (hydromorphone) = crush and extraction resistant. • Oxecta (IR oxycodone) = aversion. • Oxycontin (CR oxycodone) = crush and extraction resistance, aversion. • Opana ER (oxymorphone) = crush and extraction resistance, aversion. 21
  • 22. Future directions23 • Monitoring for side-effects. • Expand prescription drug monitoring programs to multi- states. • Tighten up regulations on illegal substances or prescription drug redistribution among patients. • Provide interventions right away if patients start to experience withdrawal symptoms. • Encourage patients to enroll in rehab programs. • More patient education. 22
  • 23. Reference 1. FDA Moves Quickly to Approve Easy-to-use Nasal Spray to Treat Opioid Overdose. U.S. Food and Drug Administration. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/UCM47 3505. Last updated 11/19/2015. Accessed 11/27/2015. 2. Narcan Approval History. http://www.drugs.com/history/narcan.html. Accessed 11/27/2015. 3. What Are Opioids? National Institute on Drug Abuse. http://www.drugabuse.gov/publications/research-reports/prescription- drugs/opioids/what-are-opioids. Accessed on 11/27/2015. 4. Al-Hasani, R, Bruchas MR. Molecular Mechanisms of Opioid Receptor- Dependent Signaling and Behavior. Anesthesiology. 2011 Dec; 115(6): 1363-1381. 5. DiPiro, JT, Talbert RL, Yee, GC, et al. Opioid. In: Pharmacotherapy: A Pathaophysiology Approach. 9e. United States: McGraw-Hill Education; 2014. 6. Swegle JM, Logemann C. Management of Common Opioid-Induced Adverse Effects. Am Fam Physician. 2006 Oct 15;74(8):1347-1354. 7. Rahman A, Choudhary MI. Frontiers in CNS Drug Discovery. Bentham Science Publishers, Jan 1,2010. 8. Ballantyne JC, Sullivan MD, Kolodny A. Opioid Dependence vs Addiction. Arch Intern Med. 2012; 172(17):1342-1343 23
  • 24. Reference 9. Pretorius RW, Zurick GM. A Systematic Approach to Identifying Drug-Seeking Patients. Fam Pract Manag. 2008 Apr; 15(4):A3-A5. 10. Spera B. How to Spot and Handle Fake Rxs. http://drugtopics.modernmedicine.com/drug- topics/news/clinical/community-pharmacy/how-spot-and-handle-fake-rxs?page=full. Last updated 8/6/2007. Accessed 11/27/2015. 11. Medication and Counseling Treatment. Substance Abuse and Mental Health Service Administration. http://www.samhsa.gov/medication-assisted- treatment/treatment#medications-used-in-mat. Last updated 9/28/2015. Accessed 11/27/2015. 12. CNS depressants. National Institute on Drug Abuse. http://www.drugabuse.gov/publications/research-reports/prescription-drugs/cns-depressants. Last updated 11/2014. Accessed 11/27/2015. 13. Opioid Overdose. Substance Abuse and Mental Health Service Administration. http://www.samhsa.gov/medication-assisted-treatment/treatment/opioid-overdose. Last updated 9/25/2015. Accessed 11/25/2015. 14. Federal Guidelines for Opioid Treatment Programs. Substance Abuse and Mental Health Service Administration. http://store.samhsa.gov/shin/content//PEP15- FEDGUIDEOTP/PEP15-FEDGUIDEOTP.pdf. Last updated 3/2015. Accessed 11/27/2015. 15. Furlano, E. Naloxone’s Basic Benefit. http://www.emsworld.com/article/11625142/naloxone- use-by-emts. EMSWorld. Last updated 10/15/2014. Accessed 11/27/2015. 16. Nasal Spray Naloxone One Step Closer to Public Availability, National Institue on Drug Abuse. https://www.drugabuse.gov/news-events/news-releases/2015/06/nasal-spray- naloxone-one-step-closer-to-public-availability. Last updated 6/12/2015. Accessed 24
  • 25. Reference 17. Kim D, Irwin KS, Khoshnood K. Expanded Access to Naloxone: Options for Critical Response to The Epidemic of Opioid Overdose Mortality. AM J Public Health. 2009 March;99(3): 402-407. 18. Overdose Prevention and Survival. The Drug Overdose Prevention and Education Project. http://harmreduction.org/wp-content/uploads/2012/02/dope-brochure-sept- 2010.pdf. Accessed 11/27/2015. 19. CVS to Sell Over-the-counter Narcan in 12 New States. http://www.ems1.com/ems- news/9948048-CVS-to-sell-over-the-counter-Narcan-in-12-new-states/ Last updated 9/30/2015. Accessed 11/27/2015. 20. CVS Set to Expand Drug Reversing Effect of Heroin Overdoses. http://www.nbcnews.com/nightly-news/video/cvs-set-to-expand-drug-reversing-effect- of-heroin-overdoses-533323331609. Last updated 9/27/2015. Accessed 11/27/2015. 21. Abuse-Deterrent Opioids – Evaluation and Labeling- Draft. U.S. Food and Drug Administration. http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm 334807.htm. Accessed 11/27/2015. 22. Opioids with Abuse Deterrent Properties. http://www.empr.com/clinical-charts/opioids- with-abuse-deterrent-properties/article/333126/. Last updated 2/7/2014. Accessed 11/27/2015. 23. Opioid Overdose ToolKit. Substance Abuse and Mental Health Service Administration. https://store.samhsa.gov/shin/content/SMA13-4742/Overdose_Toolkit_2014_Jan.pdf. 25

Notes de l'éditeur

  1. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/UCM473505 http://www.drugs.com/history/narcan.html Fast track is a process designed to facilitate development and expedite review of drugs intended to treat serious conditions and that demonstrate the potential to address an unmet medical need. The agency’s priority review program provides for an expedited review of drugs that offer a significant improvement in the safety or effectiveness of the treatment, prevention, or diagnosis of a serious condition.
  2. So how serious was opioid overdose that took only 4 months to approve nasal spray? Death due to drug overdose MOSTLY PRESCRIPTION DRUGS is now number 1 cause of injury death in the U.S. Surpassed motor vehicle crashes Risk of contaminated needle stick = Healthcare worker accidentally stab themselves after patient got back to life and got angry for taking away their “high” Risk of blood-borne diseases exposed to healthcare workers
  3. Before the nasal spray formulation was approved, this is the nasal spray form of injection
  4. Only heroin and opium are illegal drugs Hydrocodone is the most commonly prescribed opioid. Gone from C-III to C-II last October 2014. Hydrocodone = dental and injury pain. Morphine = severe pain after surgery, cancer pain. Codeine = mild pain and cough, severe diarrhea http://www.drugabuse.gov/publications/research-reports/prescription-drugs/opioids/what-are-opioids http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698859/
  5. Sedation, as opioid is depressing central nervous system to reduce pain Treatment may involve stimulants like Dextroamphetamine, methylphenidate Lower blood pressure If blood pressure is too low, need to reverse with Naloxone or a steroid like dexamethasone. Induced constipation because it can bind to opioid receptors in the GI tract and could slow down bowel movement significantly. PREVENTION dose = Senna + Docusate Or switch to Fentanyl Opioid can activate mast cell and release of histamine causing itching, different opioid has different amount of histamine releasing. Morphine, Codeine, Meperidine causes a lot of itching. Tx= Antihistamine 2nd gen that cause less drowsy (opioid causes sedation already) Acid reflux Due to reduce gastric motility Tx: antacid, ranitidine, omeprazole N/V occur in about 25% patients Require antiemetic (meclizine) with an antipsychotic (Haloperiodol), prokinetic (Reglan), or serotonin antagonist (ondansetron). No antiemetic is superior to other, so it comes down to cost and pt preference. Respiratory arrest Tx = Naloxone to reverse http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698859/ DIPIRO http://www.aafp.org/afp/2006/1015/p1347.htmlhttp://www.aafp.org/afp/2006/1015/p1347.html https://books.google.com/books?id=ip-Pz5C3_loC&pg=PA491&lpg=PA491&dq=steroid+for+opioid+induced+hypotension&source=bl&ots=G7UmAyCp8_&sig=wOfymldvLM3p-yyMvZ8n02o4JQY&hl=en&sa=X&ved=0ahUKEwicq5ugqq7JAhVC9x4KHXa6CkMQ6AEIMjAC#v=onepage&q=steroid%20for%20opioid%20induced%20hypotension&f=false
  6. Adaptation is a normal process of the body. There are 2 adaptation involved: Tolerance = the bar has been increased BODY ARE ADAPTED. dose needs to be increased too to achieve the same effect. Dependence = the physiologic/body responses due to: Increase in tolerance but dose is not increased to compensate. Stopping opioid. What are some withdrawal symptoms: sweating, jittery, anxiety, insomnia, restlessness, nausea vomiting, muscle and bone pain, cold flashes. http://archinte.jamanetwork.com/article.aspx?articleid=1309576
  7. Fake prescriptions Very nice hand and neat hand writin Not a regular or LOCAL customer – patients lives 50 miles away Large quantity without insurance and paying cash. Condition and quantity dont match (dental procedure and 120 percocet) TAMPERED (written over by patients) Paper doesnt feel/look right (purposely folded, wrinkled, old) OUT OF AREA prescriber Anybody knows other ways? What to do if you identify a fake script? Call the police Have the patients sit and wait and then call the police. Refuse to fill (we do not have the medication), give the ID information to the police. http://www.aafp.org/fpm/2008/0400/pa3.html http://drugtopics.modernmedicine.com/drug-topics/news/clinical/community-pharmacy/how-spot-and-handle-fake-rxs?page=full
  8. for addiction to short-acting opioids Methadone Tricks the brain into thinking it’s still getting the abused drug. In fact, the person is not getting high from it and feels normal, so withdrawal doesn’t occur. Pregnant or breastfeeding women must inform their treatment provider before taking methadone. Only drug approved for pregnant or breastfeeding. Buprenorphine = Suppress and reduce craving Naltrexone = Block the euphoric and sedative effect of abused drugs http://www.samhsa.gov/medication-assisted-treatment/treatment#medications-used-in-mat
  9. You guys have seen a lot of bad things about opioid, but you guys should not avoid using it. Slowed breathing -> reduced oxygen delivery -> coma, permanent brain damage White matter = Affect ability to make decision, regulate behavior and responses to stress. http://www.drugabuse.gov/publications/research-reports/prescription-drugs/cns-depressants
  10. Here is the list of the reasons why overdose occurs It could be someone that accidentally…taken extra doses. Ex: Elderly that wakes up during the night, couldn’t see well, read ½ on bottle as 12 tablets it could be someone that purposely that extra doses for the euphoria or to get high. Children and pet = childsafety cap and in locked cabinet. Give to someone, some medication might work well for you, but not for the others. Ex: giving percocet for headache. Certain medication interactions can increase opioid retention in the body. Ex: Fentanyl and oxycodone = Cyp 3A4. Tramadol is also 3A4, Grape fruit juice, certain OTC herbals like ginseng. Recreational use Release opioid slowly. People may snort or inject to get the reward sensation. http://www.samhsa.gov/medication-assisted-treatment/treatment/opioid-overdose
  11. http://www.samhsa.gov/medication-assisted-treatment/treatment/opioid-overdose
  12. CPR = Cardio Pulmonary Resuscitation. To protect yourself, do CPR only if you are certified. http://www.samhsa.gov/medication-assisted-treatment/treatment/opioid-overdose http://store.samhsa.gov/product/Federal-Guidelines-for-Opioid-Treatment-Programs/PEP15-FEDGUIDEOTP
  13. Risk of needle stick because addicts are violent Hep B, Hep C, HIV, etc. http://www.emsworld.com/article/11625142/naloxone-use-by-emts https://www.drugabuse.gov/news-events/news-releases/2015/06/nasal-spray-naloxone-one-step-closer-to-public-availability http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2661437/
  14. Administer full dose to one nostril or half dose to each nostril. http://harmreduction.org/wp-content/uploads/2012/02/dope-brochure-sept-2010.pdf
  15. The injection one requires assembly The newly approved nasal formulation is READY TO USE,
  16. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm473505.htm http://www.ems1.com/ems-news/9948048-CVS-to-sell-over-the-counter-Narcan-in-12-new-states/ http://www.nbcnews.com/nightly-news/video/cvs-set-to-expand-drug-reversing-effect-of-heroin-overdoses-533323331609
  17. NASAL RESCUE KITS Two 2 ml luer jet luer lock syringes prefilled with naloxone (1mg/ml) Two mucosal atomization devices Intormation pamphlet with overdose prevention and step by step instructions for overdose responses and naloxone administration MUSCLE RESCUE KITS 1 10 ml multidose fliptop vial OR 2 1 ml vials 2 intramuscular syringes, 25 G 3 cc 1in Patient information pamphlet
  18. Instruction labeling: TYPE OUT ½ as ONE HALF can help elderly see better Always consult with your doctor or pharmacist if you do not know how to take medications Pillbox: take 1 to 2 tablets every 4 to 6 hours. Max 5 tabs a day. Mix with other medication: sleeping pills, anxiety medications, allergy medications, other opioids http://www.samhsa.gov/medication-assisted-treatment/treatment/opioid-overdose
  19. Safety cap or store in a high and lock cabinet = Out of reach of children and pet.
  20. Physical or chemical barriers Physcial = Prevent crushing and snorting Chemical = Prevent extraction when using common solvent like water, alcohol or orgnaic solvents. Agonist + antagonist combination To defeat the euphoria associated with abuse. Antagonist is released only upon manipulation Inactive when swallow Active when crushed, injected, or snorted Aversion Produce an unpleasant effect (nauseating, vomitting) if higher dose is used or drug is manipulated Delivery system Example an implant, a sustained-release depot injectable can be difficult to manipulate Prodrug Only become active in GI tract, making other routes like IV, nasal ineffective. Combination of methods above Oxecta = AVERSION, if dissolve for IV, create a viscous gelatinous mixture trappin goxycodone inside http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm334807.htm http://www.empr.com/clinical-charts/opioids-with-abuse-deterrent-properties/article/333126/
  21. PDMP = Records that can be accessed by pharmacists in all states. Redistribution: Ex: black market selling of opioid. https://store.samhsa.gov/shin/content/SMA13-4742/Overdose_Toolkit_2014_Jan.pdf
  22. So why autoinjector and still risk of injection? Because autoinjector is for home-use, but not a lot of lay people know the symptoms of opioid overdose, so mostly they don’t use Evzio, hospital use syringe type of injection. Kinetics? Same Safe? Safer